Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
The World Needs New Antibiotics, but the Business Model Is Broken
New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link
Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
Deal on China Flights Signals U.S. Airlines' Stronger Hand
Both sides stay civil even as the Biden administration’s go-slow policy frustrates Beijing’s hopes of a faster aviation-market reopening. Source link
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
China's Worsening Economy Is Hurting Corporate America
Caterpillar and DuPont are among the big companies that are lowering their expectations for a postpandemic boom. Source link
Could Scientist Find Drug to Treat His Own Disease?
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
U.S. and China Poised to Drift Further Apart After Investment Ban
What to Read Next Source link
China Slips Into Deflation in Warning Sign for Global Economy
China entered deflationary territory for the first time in two years, pressuring Beijing to avoid a deepening economic malaise. Source link
